Comparative effectiveness of robot-assisted versus open radical prostatectomy cancer control

European Urology

Volumn 66, Issue 4, 2014, Pages 666-672

  Hu, Jim C ^a   Gandaglia, Giorgio ^b,c   Karakiewicz, Pierre I ^b   Nguyen, Paul L ^d   Trinh, Quoc Dien ^d   Shih, Ya Chen Tina ^e   Abdollah, Firas ^b   Chamie, Karim ^a   Wright, Jonathan L ^f   Ganz, Patricia A ^a   Sun, Maxine ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b CENTRE HOSPITALIER DE L UNIVERSITÉ DE MONTRÉAL   (Canada)

^c VITA SALUTE SAN RAFFAELE UNIVERSITY   (Italy)

^d BRIGHAM AND WOMEN S HOSPITAL   (United States)

^e UNIVERSITY OF CHICAGO   (United States)

^f UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

Cancer control; Positive margins; Radical prostatectomy; Robotic assisted surgery

Indexed keywords

PROSTATE SPECIFIC ANTIGEN; ANTIANDROGEN;

AGED; ANDROGEN DEPRIVATION THERAPY; ARTICLE; CANCER CONTROL; CANCER INCIDENCE; CANCER RADIOTHERAPY; CANCER RISK; CANCER SURGERY; COMPARATIVE EFFECTIVENESS; CONTROLLED STUDY; DEMOGRAPHY; DIGITAL RECTAL EXAMINATION; GLEASON SCORE; HUMAN; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; OBSERVATIONAL STUDY; OPEN RADICAL PROSTATECTOMY; PALPATION; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATECTOMY; RETROSPECTIVE STUDY; ROBOT ASSISTED RADICAL PROSTATECTOMY; ROBOTICS; SURGICAL APPROACH; ADVERSE EFFECTS; BLOOD; CANCER STAGING; COHORT ANALYSIS; COMPARATIVE STUDY; CONFIDENCE INTERVAL; FOLLOW UP; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; PATHOLOGY; PATIENT SAFETY; PROCEDURES; PROSTATIC NEOPLASMS; RISK; RISK ASSESSMENT; ROBOTIC SURGICAL PROCEDURE; STATISTICAL MODEL; TREATMENT OUTCOME; TUMOR INVASION; ANTIANDROGEN THERAPY; CANCER HORMONE THERAPY; CANCER RECURRENCE; MULTIMODALITY CANCER THERAPY; OUTCOME ASSESSMENT; SURGICAL RISK; ANASTOMOSIS STENOSIS; BIOCHEMICAL RECURRENCE FREE SURVIVAL; BLOOD TRANSFUSION; CANCER MORTALITY; CANCER PROGNOSIS; CANCER REGISTRY; CANCER SURVIVAL; CANCER THERAPY; DISEASE SEVERITY; ERECTILE DYSFUNCTION; HEALTH CARE UTILIZATION; HIGH RISK PATIENT; INTERMEDIATE RISK PATIENT; LEARNING CURVE; LENGTH OF STAY; NOTE; POSTOPERATIVE CARE; PROPENSITY SCORE; ROBOT ASSISTED PROSTATECTOMY; SEMINAL VESICLE; SURGEON; URINE INCONTINENCE;

AGED; COHORT STUDIES; CONFIDENCE INTERVALS; FOLLOW-UP STUDIES; HUMANS; LINEAR MODELS; MALE; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; ODDS RATIO; PATIENT SAFETY; PROSTATE-SPECIFIC ANTIGEN; PROSTATECTOMY; PROSTATIC NEOPLASMS; RETROSPECTIVE STUDIES; RISK ASSESSMENT; ROBOTIC SURGICAL PROCEDURES; TREATMENT OUTCOME;

EID: 84908357247     PISSN: 03022838     EISSN: 18737560     Source Type: Journal    
DOI: 10.1016/j.eururo.2014.02.015     Document Type: Article

References (44)

1. R. Siegel, D. Naishadham, and A. Jemal Cancer statistics, 2013 CA Cancer J Clin 63 2013 11 30
2. J.C. Hu, X. Gu, and S.R. Lipsitz et al. Comparative effectiveness of minimally invasive vs open radical prostatectomy JAMA 302 2009 1557 1564
3. V. Ficarra, G. Novara, and R.C. Rosen et al. Systematic review and meta-analysis of studies reporting urinary continence recovery after robot-assisted radical prostatectomy Eur Urol 62 2012 405 417
4. C. Bolenz, S.J. Freedland, and B.K. Hollenbeck et al. Costs of radical prostatectomy for prostate cancer: a systematic review Eur Urol 65 2014 316 324
5. P. Sooriakumaran, L. Haendler, and T. Nyberg et al. Biochemical recurrence after robot-assisted radical prostatectomy in a European single-centre cohort with a minimum follow-up time of 5 years Eur Urol 62 2012 768 774
6. J.M. Hubanks, E.C. Umbreit, R.J. Karnes, and R.P. Myers Open radical retropubic prostatectomy using high anterior release of the levator fascia and constant haptic feedback in bilateral neurovascular bundle preservation plus early postoperative phosphodiesterase type 5 inhibition: a contemporary series Eur Urol 61 2012 878 884
7. M.A. Simon, S. Kim, and M.S. Soloway Prostate specific antigen recurrence rates are low after radical retropubic prostatectomy and positive margins J Urol 175 2006 140 144 discussion 144-5
8. P. Swindle, J.A. Eastham, and M. Ohori et al. Do margins matter? The prognostic significance of positive surgical margins in radical prostatectomy specimens J Urol 179 Suppl 5 2008 S47 S51
9. J.L. Wright, B.L. Dalkin, and L.D. True et al. Positive surgical margins at radical prostatectomy predict prostate cancer specific mortality J Urol 183 2010 2213 2218
10. H.J. Chalfin, M. Dinizo, and B.J. Trock et al. Impact of surgical margin status on prostate-cancer-specific mortality BJU Int 110 2012 1684 1689
11. J.A. Eastham, M.W. Kattan, and E. Riedel et al. Variations among individual surgeons in the rate of positive surgical margins in radical prostatectomy specimens J Urol 170 2003 2292 2295
12. J.L. Warren, C.N. Klabunde, D. Schrag, P.B. Bach, and G.F. Riley Overview of the SEER-Medicare data - content, research applications, and generalizability to the United States elderly population Med Care 40 Suppl 8 2002 IV-3-18
13. Y.N. Wong, N. Mitra, and G. Hudes et al. Survival associated with treatment vs observation of localized prostate cancer in elderly men JAMA 296 2006 2683 2693
14. M. Sun, F. Abdollah, and D. Liberman et al. Racial disparities and socioeconomic status in men diagnosed with testicular germ cell tumors: a survival analysis Cancer 117 2011 4277 4285
15. A.V. D'Amico, R. Whittington, and S.B. Malkowicz et al. Biochemical outcome after radical prostatectomy, external beam radiation therapy, or interstitial radiation therapy for clinically localized prostate cancer JAMA 280 1998 969 974
16. C.N. Klabunde, A.L. Potosky, J.M. Legler, and J.L. Warren Development of a comorbidity index using physician claims data J Clin Epidemiol 53 2000 1258 1267
17. J.C. Hu, K.F. Gold, C.L. Pashos, S.S. Mehta, and M.S. Litwin Temporal trends in radical prostatectomy complications from 1991 to 1998 J Urol 169 2003 1443 1448
18. W.T. Lowrance, J.A. Rumohr, S.S. Chang, P.E. Clark, J.A. Smith, and M.S. Cookson Contemporary open radical cystectomy: analysis of perioperative outcomes J Urol 179 2008 1313 1318 discussion 1318
19. Gandaglia G, Sammon J, Chang S, et al. Comparative effectiveness of robotic-assisted and open radical prostatectomy in the post-dissemination era. J Clin Oncol. In press. http://dx.doi.org/10.1200/jco.2013.53.5096.
20. S.B. Williams, A.V. D'Amico, A.C. Weinberg, X. Gu, S.R. Lipsitz, and J.C. Hu Population-based determinants of radical prostatectomy surgical margin positivity BJU Int 107 2011 1734 1740
21. R.B. D'Agostino Propensity score methods for bias reduction in the comparison of a treatment to a nonrandomized control group Stat Med 17 1998 2265 2281
22. Leonhardt D. In health reform, a cancer offers an acid test. New York Times. July 7, 2009. http://www.nytimes.com/2009/07/08/business/economy/ 08leonhardt.html.
23. G.I. Barbash, and S.A. Glied New technology and health care costs - the case of robot-assisted surgery N Engl J Med 363 2010 701 704
24. B.L. Jacobs, Y. Zhang, and F.R. Schroeck et al. Use of advanced treatment technologies among men at low risk of dying from prostate cancer JAMA 309 2013 2587 2595
25. F.R. Schroeck, T.L. Krupski, and L. Sun et al. Satisfaction and regret after open retropubic or robot-assisted laparoscopic radical prostatectomy Eur Urol 54 2008 785 793
26. J.D. Wright, and D.L. Hershman Robotic vs laparoscopic hysterectomy - reply JAMA 309 2013 2320 2321
27. Langreth R. Intuitive robot probe threatens trend-setting surgeries. Bloomberg Web site. http://www.bloomberg.com/news/2013-02-28/intuitive-surgical- robots-probed-by-u-s-in-survey-of-surgeons.html.
28. Langreth R. Robosurgery suits detail injuries as death reports rise. Bloomberg Web site. http://www.bloomberg.com/news/2013-03-05/robosurgery-suits- detail-injuries-as-death-reports-rise.html.
29. A. Vaidya, C. Hawke, R. Tiguert, F. Civantos, and M. Soloway Intraoperative T staging in radical retropubic prostatectomy: is it reliable? Urology 57 2001 949 954
30. A.K. Tewari, N.D. Patel, and R.A. Leung et al. Visual cues as a surrogate for tactile feedback during robotic-assisted laparoscopic prostatectomy: posterolateral margin rates in 1340 consecutive patients BJU Int 106 2010 528 536
31. S.A. Boorjian, R.J. Karnes, and P.L. Crispen et al. The impact of positive surgical margins on mortality following radical prostatectomy during the prostate specific antigen era J Urol 183 2010 1003 1009
32. Y.M. Hong, J.C. Hu, A.T. Paciorek, S.J. Knight, and P.R. Carroll Impact of radical prostatectomy positive surgical margins on fear of cancer recurrence: results from CaPSURE Urol Oncol 28 2010 268 273
33. K.E. Hoffman, P.L. Nguyen, and M.H. Chen et al. Recommendations for post-prostatectomy radiation therapy in the United States before and after the presentation of randomized trials J Urol 185 2011 116 120
34. C.M. Moinpour, K.A. Hayden, and J.M. Unger et al. Health-related quality of life results in pathologic stage C prostate cancer from a Southwest Oncology Group trial comparing radical prostatectomy alone with radical prostatectomy plus radiation therapy J Clin Oncol 26 2008 112 120
35. S.B. Williams, X. Gu, S.R. Lipsitz, P.L. Nguyen, T.K. Choueiri, and J.C. Hu Utilization and expense of adjuvant cancer therapies following radical prostatectomy Cancer 117 2011 4846 4854
36. J.J. Tomaszewski, J.C. Matchett, B.J. Davies, S.V. Jackman, R.L. Hrebinko, and J.B. Nelson Comparative hospital cost-analysis of open and robotic-assisted radical prostatectomy Urology 80 2012 126 129
37. I.M. Thompson, C.M. Tangen, and J. Paradelo et al. Adjuvant radiotherapy for pathological T3N0M0 prostate cancer significantly reduces risk of metastases and improves survival: long-term followup of a randomized clinical trial J Urol 181 2009 956 962
38. I.M. Thompson Jr., C.M. Tangen, and J. Paradelo et al. Adjuvant radiotherapy for pathologically advanced prostate cancer: a randomized clinical trial JAMA 296 2006 2329 2335
39. M. Bolla, H. van Poppel, and L. Collette et al. Postoperative radiotherapy after radical prostatectomy: a randomised controlled trial (EORTC trial 22911) Lancet 366 2005 572 578
40. K. Moon, G.J. Stukenborg, J. Keim, and D. Theodorescu Cancer incidence after localized therapy for prostate cancer Cancer 107 2006 991 998
41. N.L. Keating, A.J. O'Malley, and M.R. Smith Diabetes and cardiovascular disease during androgen deprivation therapy for prostate cancer J Clin Oncol 24 2006 4448 4456
42. P. Sooriakumaran, A. Srivastava, and S.F. Shariat et al. A multinational, multi-institutional study comparing positive surgical margin rates among 22 393 open, laparoscopic, and robot-assisted radical prostatectomy patients Eur Urol 66 2014 450 456
43. M.G. Sanda, R.L. Dunn, and J. Michalski et al. Quality of life and satisfaction with outcome among prostate-cancer survivors N Engl J Med 358 2008 1250 1261
44. S.K. Shah, T.M. Fleet, V. Williams, A.Y. Smith, B. Skipper, and C. Wiggins SEER coding standards result in underestimation of positive surgical margin incidence at radical prostatectomy: results of a systematic audit J Urol 186 2011 855 859